Poseida Therapeutics share price today

(PSTX)

Poseida Therapeutics share price is $9.45 & ₹803.02 as on 21 Dec 2024, 2.30 'hrs' IST

$9.45

▲

0.04

(0.43%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Poseida Therapeutics share price in Dollar and Rupees. Guide to invest in Poseida Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Poseida Therapeutics. Get details on the Indian mutual funds that are investing in Poseida Therapeutics. Get Analyst recommendations and forecasts along with all the Poseida Therapeutics's financials.

Poseida Therapeutics share price movements

Today's Low: $9.36
Today's High: $9.48
$9.45
0.95%
Downside
Day's Volatility :1.27%
Upside
0.32%
52 Weeks Low: $1.87
52 Weeks High: $9.58
$9.45
80.21%
Downside
52 Weeks Volatility :80.48%
Upside
1.36%

Poseida Therapeutics Returns

Period	Poseida Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	205.83%	-11.1%	0.0%
6 Months	243.64%	-6.0%	0.0%
1 Year	181.25%	2.7%	0.0%
3 Years	37.96%	0.6%	-19.7%

Poseida Therapeutics Key Statistics

in dollars & INR

Previous Close	$9.41
Open	$9.38
Today's High	$9.48
Today's Low	$9.36
Market Capitalization	$917.2M
Today's Volume	$2.0M
52 Week High	$9.58
52 Week Low	$1.87
Revenue TTM	$150.9M
EBITDA	$-57.0M
Earnings Per Share (EPS)	$-0.63
Profit Margin	-40.28%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-57.63%

How to invest in Poseida Therapeutics from India?

It is very easy for Indian residents to invest directly in Poseida Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Poseida Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Poseida Therapeutics or PSTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Poseida Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Poseida Therapeutics shares which would translate to 0.090 fractional shares of Poseida Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Poseida Therapeutics, in just a few clicks!

Returns in Poseida Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Poseida Therapeutics investment value today

Current value as on today

₹2,83,446

Returns

₹1,83,446

(+183.45%)

Returns from Poseida Therapeutics Stock

₹1,81,250 (+181.25%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Poseida Therapeutics

12100.0%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Poseida Therapeutics from India has grown in the last 30 days as on Dec 21, 2024. 12100.0% more purchase transactions for Poseida Therapeutics in the last 30 days versus the previous period.

791%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Poseida Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 791% more investors are searching Poseida Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Poseida Therapeutics

FMR Inc
14.95%
Pentwater Capital Management LP
6.13%
BlackRock Inc
5.03%
SILVERARC CAPITAL MANAGEMENT, LLC
3.78%
Vanguard Group Inc
3.76%
Millennium Management LLC
2.25%

Analyst Recommendation on Poseida Therapeutics

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Poseida Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Poseida Therapeutics

What analysts predicted

Upside of 0.53%

Current:

$9.45

Target:

$9.50

Insights on Poseida Therapeutics

Price Movement
In the last 1 month, PSTX stock has moved up by 248.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 25.97M → 71.74M (in $), with an average increase of 63.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -31.37M → 20.23M (in $), with an average increase of 255.0% per quarter

Poseida Therapeutics Technicals Summary

Sell

Neutral

Buy

Poseida Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Poseida Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Poseida Therapeutics Inc	248.71%	243.64%	181.25%	37.96%	-38.44%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Poseida Therapeutics Inc	NA	NA	NA	-0.73	-0.58	-0.13	NA	0.9
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Poseida Therapeutics Inc	Buy	$917.2M	-38.44%	NA	-40.28%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Poseida Therapeutics

poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes and/or technologies. proprietary tools include piggybac™ dna modification system, nextgen™ crispr, xtn™ talen and footprint-free™ gene editing system, which are clean (synthetic and virus-free) and can be surgically precise. poseida aims to shuttle the first car-t and gene therapy product candidates into phase i clinical trials in early 2016. poseida is now hiring and searching for ambitious and motivated scientists desiring a fast-paced work environment with diverse research opportunities in the field of cellular and gene therapy.

Organization	Poseida Therapeutics
Employees	350
CEO	Mr. Mark J. Gergen J.D.
Industry	Health Technology

Management People of Poseida Therapeutics

Name	Title
Mr. Mark J. Gergen J.D.	Executive Chairman of the Board
Dr. Kristin Yarema Ph.D.	President, CEO & Director
Ms. Johanna M. Mylet CPA	Chief Financial Officer
Mr. Loren Wagner	Chief Operations Officer
Ms. Kristin Martin	Chief People & Administration Officer
Mr. Alexander Chapman	Senior VP of Investor Relations & Corporate Communications
Mr. Harry J. Leonhardt Esq., J.D.	General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Devon J. Shedlock Ph.D.	Chief Scientific Officer of Cell Therapy
Ms. Lisa Portale	Senior Vice President of Regulatory Affairs
Dr. Jeffrey W. Winkelman J.D., Ph.D.	Senior VP & Chief Patent Counsel

Important FAQs about investing in Poseida Therapeutics from India :

What is Poseida Therapeutics share price today?

Poseida Therapeutics share price today stands at $9.45, Open: $9.38 ; Previous Close: $9.41 ; High: $9.48 ; Low: $9.36 ; 52 Week High: $9.58 ; 52 Week Low: $1.87. The stock opens at $9.38, after a previous close of $9.41. The stock reached a daily high of $9.48 and a low of $9.36, with a 52-week high of $9.58 and a 52-week low of $1.87.

Can Indians buy Poseida Therapeutics shares?

Yes, Indians can invest in the Poseida Therapeutics (PSTX) from India.

With INDmoney, you can buy Poseida Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Poseida Therapeutics at zero transaction cost.

How can I buy Poseida Therapeutics shares from India?

It is very easy to buy Poseida Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Poseida Therapeutics be purchased?

Yes, you can buy fractional shares of Poseida Therapeutics with INDmoney app.

What are the documents required to start investing in Poseida Therapeutics stocks?

To start investing in Poseida Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.